Anonymous ID: d533ff Jan. 24, 2022, 4:36 p.m. No.15452899   🗄️.is đź”—kun   >>3119 >>3319 >>3458

https://www.vitalant.org/Hidden-Pages/COVID-FAQs

 

FREQUENTLY ASKED QUESTIONS - MASKS

 

Are masks required at blood drives?

To support a safe environment, effective Aug. 9, masks are required for donors, staff and guests at Vitalant blood drives and facilities regardless of vaccination status. Thank you for your understanding as we all continue to navigate through this pandemic.

o Vitalant continues to follow CDC and OSHA guidance when determining our COVID-19 safety policies.

o The CDC’s latest guidance on July 27 recommends masks for vaccinated individuals indoors in high-risk areas as well as for those unvaccinated.

o Like other blood services providers, Vitalant made the decision to err on the side of safety and require masks for everyone at this time.

o Vitalant will continue to have masks available for those who need one.

What if I don’t want to/can’t wear a mask?

Thank you for your support of our lifesaving mission. At this time, we ask you to postpone your donation until guidance changes.

Can I wear a face shield instead?

No. We ask that you wear a mask or reasonable cloth-based face covering. The CDC does not recommend using a face shield as a substitute. Also, masks with valves are not permitted.

 

all this over your behavior in the donation booth, yet…

 

Can people get coronavirus from donating blood/receiving a blood transfusion?

 

COVID-19 continues to pose no known risk to patients receiving blood transfusions. There are no reported cases of transmission of this virus via blood transfusion. There is no inherent risk of getting coronavirus from the donation procedure itself.

Anonymous ID: d533ff Jan. 24, 2022, 4:56 p.m. No.15453050   🗄️.is đź”—kun

>>15453024

what caused the radiation poisoning/cancers? what can you believe any more. nothing.

 

Within the first few months after the bombing, it is estimated by the Radiation Effects Research Foundation (a cooperative Japan-U.S. organization) that between 90,000 and 166,000 people died in Hiroshima, while another 60,000 to 80,000 died in Nagasaki. These deaths include those who died due to the force and excruciating heat of the explosions as well as deaths caused by acute radiation exposure.

 

While these numbers represent imprecise estimates—due to the fact that it is unknown how many forced laborers and military personnel were present in the city and that in many cases entire families were killed, leaving no one to report the deaths—statistics regarding the long term effects have been even more difficult to determine.

 

Though exposure to radiation can cause acute, near-immediate effect by killing cells and directly damaging tissue, radiation can also have effects that happen on longer scale, such as cancer, by causing mutations in the DNA of living cells. Mutations can occur spontaneously, but a mutagen like radiation increases the likelihood of a mutation taking place. In theory, ionizing radiation can deposit molecular-bond-breaking energy, which can damage DNA, thus altering genes. In response, a cell will either repair the gene, die, or retain the mutation. In order for a mutation to cause cancer, it is believed that a series of mutations must accumulate in a given cell and its progeny. For this reason, it may be many years after exposure before an increase in the incident rate of cancer due to radiation becomes evident.

 

Among the long-term effects suffered by atomic bomb survivors, the most deadly was leukemia. An increase in leukemia appeared about two years after the attacks and peaked around four to six years later. Children represent the population that was affected most severely. Attributable risk—the percent difference in the incidence rate of a condition between an exposed population and a comparable unexposed one — reveals how great of an effect radiation had on leukemia incidence. The Radiation Effects Research Foundation estimates the attributable risk of leukemia to be 46% for bomb victims.

 

For all other cancers, incidence increase did not appear until around ten years after the attacks. The increase was first noted in 1956 and soon after tumor registries were started in both Hiroshima and Nagasaki to collect data on the excess cancer risks caused by the radiation exposure. The most thorough study regarding the incidence of solid cancer (meaning cancer that is not leukemia) was conducted by a team led by Dale L. Preston of Hirosoft International Corporation and published in 2003. The study estimated the attributable rate of radiation exposure to solid cancer to be significantly lower than that for leukemia—10.7%. According to the RERF, the data corroborates the general rule that even if someone is exposed to a barely survivable whole-body radiation dose, the solid cancer risk will not be more than five times greater than the risk of an unexposed individual.

 

https://k1project.columbia.edu/news/hiroshima-and-nagasaki